Rajesh Shrotriya, Chairman and CEO of Spectrum Pharmaceuticals Inc., presides over the closing bell.

Tuesday, September 26, 2006
at NASDAQ's MarketSite
in New York City.

Spectrum Pharmaceuticals Inc.
[SPPI]

Rajesh Shrotriya, Chairman and CEO of Spectrum Pharmaceuticals Inc. (SPPI) presides over the closing bell to celebrate its 10-year listing anniversary on NASDAQ.
Spectrum Pharmaceuticals opportunistically acquires and advances a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drug candidates with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at www.spectrumpharm.com.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 9/26/2006 Download Hi-Res Quality Photo of this NASDAQ Market Close - Pictured: Rajesh Shrotriya, Chairman and CEO of Spectrum Pharmaceuticals Inc., rings the Closing Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.